Variable | |
---|---|
Age, years | 33.5 [16–78] |
Male/female | 24 (42.9%)/32 (57.1%) |
SES-CD | 7 [1–37] |
HBI (n = 55) | 5 [0–14] |
Disease distribution | |
Ileum | 29 (51.8%) |
Colon | 6 (10.7%) |
Ileocolon | 21 (37.5%) |
CRP, mg/L | 8.5 [1–139] |
F-calprotectin, mg/kg (n = 52) | 278 [15–4432] |
fVAS score | 50.5 (25.6) |
FSS score | 4.0 (1.8) |
SF-36vs scorea | 61.4 (22.9) |
SF-36bp scorea | 59 [0–100] |
HADS-D (n = 55) | 3 [0–13] |
IL-1RA, pg/mL | 292.2 [126.2–1412.3] |
sIL-1RII, ng/mL | 6.78 [3.29–49.90] |
HSP90α, ng/mL (n = 52) | 17.28 [6.44–55.06] |
HMGB1, ng/mL (n = 52) | 1.17 [0.22–3.33] |
Anti-frHMGB1 absb (n = 49) | 0.040 [0.040–1.179] |
PEDF, ng/mL (n = 46) | 655 [458–1100] |
HPX, ng/mL (n = 46) | 735.3 (224.5) |